Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1265-1272

  Ji, Dengbo ^a   Li, Ming ^a   Zhan, Tiancheng ^a   Yao, Yunfeng ^a   Shen, Jing ^a   Tian, Huifang ^a   Zhang, Zhiqian ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLYCOPROTEIN 1, ZINC BINDING PROTEIN; PEROXIREDOXIN 2; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG; ZINC BINDING PROTEIN;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84875479638     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt056     Document Type: Article

References (29)

1. Ballantyne,G.H. et al. (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer, 71, 4252-4266.
2. Locker,G.Y. et al. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol., 24, 5313-5327.
3. Duffy,M.J. et al. (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer, 43, 1348-1360.
4. Xie,L.Q. et al. (2010) Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J. Proteome Res., 9, 4701-4709.
5. Ma,Y. et al. (2009) Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol. Cell Proteomics, 8, 1878-1890.
6. Friedman,D.B. et al. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics, 4, 793-811.
7. Alfonso,P. et al. (2005) Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics, 5, 2602-2611.
8. Li,X. et al. (2005) Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics, 5, 3423-3441.
9. Díez-Itza,I. et al. (1993) Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur. J. Cancer, 29A, 1256-1260.
10. Hale,L.P. et al. (2001) Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin. Cancer Res., 7, 846-853.
11. Dawson,D.W. et al. (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science, 285, 245-248.
12. Memon,A.A. et al. (2005) Identification of differentially expressed proteins during human urinary bladder cancer progression. Cancer Detect. Prev., 29, 249-255.
13. Carta,F. et al. (2005) Analysis of candidate genes through a proteomicsbased approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res., 15, 235-244.
14. Agrawal-Singh,S. et al. (2012) Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood, 119, 2346-2357.
15. Noh,D.Y. et al. (2001) Overexpression of peroxiredoxin in human breast cancer. Anticancer Res., 21(3B), 2085-2090.
16. Li,Y. et al. (2008) Proteome analysis of aflatoxin B1-induced hepatocarcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin II. Proteomics, 8, 1490-1501.
17. Bellei,E. et al. (2008) Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients. Proteomics. Clin. Appl., 2, 478-491.
18. Rabilloud,T. et al. (1998) Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis, 19, 1006-1014.
19. Kim,H. et al. (2008) Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas. Proteomics. Clin. Appl., 2, 571-584.
20. Koumakpayi,I.H. et al. (2010) Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. Br. J. Cancer, 102, 1163-1173.
21. Burgi,W. et al. (1961) Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J. Biol. Chem., 236, 1066-1074.
22. Ohkubo,I. et al. (1990) Human seminal plasma Zn-alpha 2-glycoprotein: its purification and properties as compared with human plasma Zn-alpha 2-glycoprotein. Biochim. Biophys. Acta, 1034, 152-156.
23. Tada,T. et al. (1991) Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J. Histochem. Cytochem., 39, 1221-1226.
24. Russell,S.T. et al. (2004) Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim. Biophys. Acta, 1636, 59-68.
25. Bing,C. et al. (2004) Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc. Natl Acad. Sci. USA101, 2500-2505.
26. Frenette,G. et al. (1987) The major 40-kDa glycoprotein in human prostatic fluid is identical to Zn-alpha 2-glycoprotein. Prostate, 11, 257-270.
27. Tombran-Tink,J. et al. (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci., 30, 1700-1707.
28. Tombran-Tink,J. et al. (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res., 53, 411-414.
29. Wågsäter,D. et al. (2010) Pigment epithelium-derived factor expression in colorectal cancer patients. Cancer Invest., 28, 872-877.